Evertogen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 122.00 Cr
- Paid Up Capital ₹ 119.14 Cr
- Company Age 12 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 138.76 Cr
- Satisfied Charges ₹ 16.51 Cr
- Revenue Growth 54.51%
- Profit Growth 39.63%
- Ebitda 63.74%
- Net Worth -119.66%
- Total Assets 1.72%
About Evertogen Life Sciences
Evertogen Life Sciences Limited (ELSL) is a leading Public Limited Indian Non-Government Company incorporated in India on 11 January 2013 and has a history of 12 years. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Optimus Generics Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 122.00 Cr and a paid-up capital of Rs 119.14 Cr.
The company currently has active open charges totaling ₹138.76 Cr. The company has closed loans amounting to ₹16.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikram Mamidipudi, Subbarao Kattamuri, Sherifuddin Shaik, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232TG2013PLC085349
- Company No.
085349
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2013
- Date of AGM
08 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Evertogen Life Sciences Limited offer?
Evertogen Life Sciences Limited offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training.
Who are the key members and board of directors at Evertogen Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subbarao Kattamuri  | Managing Director | 11-Jan-2013 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikram Mamidipudi | Director | 27-Mar-2015 | Current |
| Sherifuddin Shaik | Director | 05-Jan-2024 | Current |
| Sushma Kattamuri | Director | 05-Jan-2022 | Current |
| Manav Jassal | Director | 11-Jan-2013 | Current |
| Sat Jassal | Director | 18-Jun-2021 | Current |
Financial Performance of Evertogen Life Sciences.
Evertogen Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.51% increase. The company also saw a substantial improvement in profitability, with a 39.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 119.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evertogen Life Sciences?
In 2023, Evertogen Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organosyn Life Sciences Private LimitedManav Jassal and Sat Jassal are mutual person
Facebook India Online Services Private LimitedVikram Mamidipudi is a mutual person
Shirdi Sai Electricals LimitedVikram Mamidipudi is a mutual person
Glochem Api Private LimitedVikram Mamidipudi and Subbarao Kattamuri are mutual person
Ahlada Engineers LimitedVikram Mamidipudi is a mutual person
Sai Silks (Kalamandir) LimitedVikram Mamidipudi is a mutual person
Charges (Loans)
₹138.76 Cr
₹16.51 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 95.00 Cr
- Others : 22.87 Cr
- Hdfc Bank Limited : 20.89 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Apr 2022 | Hdfc Bank Limited | ₹20.89 Cr | Open |
| 29 Mar 2022 | Others | ₹20.00 Cr | Open |
| 16 Sep 2020 | Axis Bank Limited | ₹5.20 Cr | Open |
| 25 Aug 2020 | Others | ₹2.87 Cr | Open |
| 07 Feb 2014 | Axis Bank Limited | ₹89.80 Cr | Open |
How Many Employees Work at Evertogen Life Sciences?
Evertogen Life Sciences has a workforce of 265 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evertogen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evertogen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
